trihexyphenidyl has been researched along with Innate Inflammatory Response in 2 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Y | 1 |
| Zhao, Z | 1 |
| Wei, X | 1 |
| Zheng, Y | 1 |
| Yu, J | 1 |
| Zheng, J | 1 |
| Wang, L | 1 |
| Yoshiyama, Y | 1 |
| Kojima, A | 1 |
| Itoh, K | 1 |
| Uchiyama, T | 1 |
| Arai, K | 1 |
2 other studies available for trihexyphenidyl and Innate Inflammatory Response
| Article | Year |
|---|---|
Long-term trihexyphenidyl exposure alters neuroimmune response and inflammation in aging rat: relevance to age and Alzheimer's disease.
Topics: Aging; Animals; Antiparkinson Agents; Brain; Calcium-Binding Proteins; Cognition Disorders; Cytokine | 2016 |
Anticholinergics boost the pathological process of neurodegeneration with increased inflammation in a tauopathy mouse model.
Topics: Animals; Benzilates; Cholinergic Antagonists; Disease Models, Animal; Hippocampus; Inflammation; Mic | 2012 |